P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans

por Hutnick, N, Carnathan, D, Dubey, S, Cox, K, Ratcliffe, S, Robertson, MN, Casimiro, DR, Ertl, HC, Betts, MR
Publicado 2009

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose

por Sholukh, AM, Siddappa, NB, Shanmuganathan, V, Lakhashe, SK, Rasmussen, RA, Watkins, JD, Vyas, HK, Mukhtar, MM, Hemashettar, G, Thorat, S, Yoon, JK, Villinger, F, Novembre, FJ, Landucci, G, Forthal, DN, Ratcliffe, S, Robert-Guroff, M, Polonis, V, Montefiori, DC, Ertl, HC, Ruprecht, RM
Publicado 2012